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Background: A new generation of troponin assays will detect levels in the majority of people, challenging the evaluation of chest pain (CP) 
patients. The significance of these findings is uncertain. We assess the association of these levels with cardiac history, risk factors and imaging in 
“low-risk” CP patients without an acute coronary syndrome (ACS).
Methods: From 8 emergency departments, 663 patients without ischemic ECG findings were assessed, of which 616 were without ACS diagnosis 
(79% with research echocardiograms). A standard troponin I (TnI) (lower limit of detection [LLOD] 15 pg/mL) and a prototype high sensitive TnI 
(hsTnI) assay (both Siemens Vista) with a LLOD of 0.5 pg/mL and 10% CV of 3 pg/mL were measured from frozen serum collected at enrollment. 
Patients were followed for 30-day chest pain readmission.
Results: For patients without an ACS diagnosis baseline characteristics included a median hsTnI of 4.9 pg/mL (inter quartile range 2.3-15.2) 
with undetectable levels in 10 (1.6%). In contrast 470 (76%) were undetectable by a current cTnI assay. Patient characteristics stratified by hsTnI 
quartiles are shown in Table. LVEF was 55±10% and not changed across quartiles.
Conclusions: Higher hsTnI levels in CP patients without ACS are associated with known cardiac disease, greater risk factor burden, increased LV 
mass and higher readmission rates. It is likely that use of hsTnI assays will result in more ACS diagnosis.
Characteristics of CP patients without ACS across hsTnI quartiles
Quartile 1
<0.5-2.2 pg/mL
n=155
Quartile 2
2.3-4.8 pg/mL
n=151
Quartile 3
4.9-15.0 pg/mL
n=155
Quartile 4
15.2-33604
n=155
P value
Age(STD) 49(10) 57(12) 60(12) 59(12) <0.001
Males (%) 62(40%) 93(61.6) 104(67.1) 109(70.3) <0.001
Hypertension (%) 74(47.7%) 100(66.2%) 124(81.0%) 132(85.2%) <0.001
Smoking (anytime) 95(61.3%) 97(64.7%) 107(69.0%) 112(73.2%) 0.018
Diabetes (%) 26(16.8%) 39(25.8%) 61(39.4%) 56(36.1%) <0.001
Coronary disease history (%) 26(16.8%) 51(33.8%) 55(35.5%) 81(52.3%) <0.001
Heart failure history (%) 9(5.8%) 5(3.3%) 28(18.3%) 57(36.8%) <0.001
Left ventricular mass index (g/m2) 96(37) 91(30) 100(40) 101(49) 0.01
CP readmission within 30 days (%) 6(4.1%) 8(5.8%) 15(9.9%) 30(20.1%) <0.001
